This site is intended for healthcare professionals

First patient enrolled in Sanofi’s phase III trial of SAR 442168 in relapsing multiple sclerosis.- Sanofi

Read time: 1 mins
Last updated:16th Mar 2021
Published:24th Jun 2020
Condition: Multiple Sclerosis
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest